Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Laboratory Monitoring After Short-Course Ceftriaxone Therapy

General Monitoring Recommendations

  • The Infectious Diseases Society of America guidelines recommend that laboratory monitoring for ceftriaxone should be based on the duration of therapy, patient risk factors, and baseline laboratory values 1
  • For short courses of ceftriaxone (≤3 days), routine monitoring of liver function tests and renal function is generally not necessary in patients with normal baseline values 1
  • The 2018 Infectious Diseases Society of America guidelines indicate that for shorter courses of ceftriaxone, it may not be necessary to monitor liver function tests and/or renal function 1

Monitoring Based on Duration

  • For standard short-course therapy (≤3 days) in patients with normal baseline values, no routine laboratory monitoring is required 1

Specific Laboratory Tests to Consider

  • Renal function tests, such as BUN and creatinine, may be considered in patients with pre-existing renal impairment, as recommended by the Infectious Diseases Society of America 1